Y-mAbs Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	62.29	67.23	78.64	105.76	181.56	114.63
Cash & Short-Term Investments	62.29	67.23	78.64	105.76	181.56	114.63
Cash Growth	-19.94%	-14.50%	-25.65%	-41.75%	58.39%	-44.66%
Receivables	15.74	19.69	22.45	12.53	7.71	-
Inventory	9.72	7.21	5.07	6.7	5.51	-
Other Current Assets	4.04	4.37	4.96	5.45	7.47	7.73
Total Current Assets	91.79	98.51	111.11	130.45	202.26	122.36
Property, Plant & Equipment	3.38	0.86	1.64	2.34	5.69	6.39
Other Intangible Assets	2.18	2.28	2.63	2.99	1.66	-
Other Long-Term Assets	19.87	18.26	12.49	5.68	3.17	3.29
Total Assets	117.21	119.9	127.87	141.46	212.78	132.05
Accounts Payable	7.57	6.66	6.06	14.18	13.55	9.37
Accrued Expenses	8.47	8.18	7.41	6.77	6.84	4.59
Current Portion of Leases	0.49	0.63	0.9	0.87	1.78	1.97
Other Current Liabilities	6.42	8.22	5.76	6.48	5.71	3.61
Total Current Liabilities	22.95	23.7	20.13	28.28	27.88	19.54
Long-Term Leases	2.64	0.19	0.52	0.9	1.85	2.01
Other Long-Term Liabilities	4.14	4.01	6.24	3.05	2.95	4.66
Total Liabilities	29.72	27.9	26.88	32.24	32.68	26.21
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	583.67	576.87	558	543.93	519.21	391.56
Retained Earnings	-495.57	-487.14	-457.47	-436.04	-340.48	-285.2
Comprehensive Income & Other	-0.61	2.26	0.45	1.33	1.37	-0.53
Shareholders' Equity	87.49	92	100.99	109.22	180.11	105.84
Total Liabilities & Equity	117.21	119.9	127.87	141.46	212.78	132.05
Total Debt	3.12	0.82	1.42	1.77	3.63	3.98
Net Cash (Debt)	59.17	66.41	77.22	104	177.93	110.66
Net Cash Growth	-22.69%	-13.99%	-25.75%	-41.55%	60.80%	-46.00%
Net Cash Per Share	1.32	1.50	1.77	2.38	4.12	2.76
Filing Date Shares Outstanding	45.44	45.22	43.78	43.68	43.71	43.53
Total Common Shares Outstanding	45.44	44.99	43.67	43.67	43.69	40.69
Working Capital	68.84	74.81	90.98	102.16	174.39	102.83
Book Value Per Share	1.93	2.05	2.31	2.50	4.12	2.60
Tangible Book Value	85.32	89.73	98.35	106.24	178.44	105.84
Tangible Book Value Per Share	1.88	1.99	2.25	2.43	4.08	2.60

Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q